Cytosorbents (CTSO) Net Margin Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,018.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1,978.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 399.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 1,966.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,966.00 |
| Dec 31, 2025 | -5,137.00 |
| Sep 30, 2025 | 11,700.00 |
| Jun 30, 2025 | 14,830.00 |
| Mar 31, 2025 | 8,622.00 |
| Dec 31, 2024 | 363.00 |
| Sep 30, 2024 | 3,350.00 |
| Jun 30, 2024 | -966.00 |
| Mar 31, 2024 | -3,140.00 |
| Dec 31, 2023 | -6,165.00 |
| Sep 30, 2023 | -9,638.00 |
| Jun 30, 2023 | -3,604.00 |
| Mar 31, 2023 | -3,787.00 |
| Dec 31, 2022 | 4,499.00 |
| Sep 30, 2022 | -3,745.00 |
| Jun 30, 2022 | -7,114.00 |
| Mar 31, 2022 | -909.00 |
| Dec 31, 2021 | 254.00 |
| Sep 30, 2021 | -1,331.00 |
| Jun 30, 2021 | 6,224.00 |